Syndicate This week's upcoming IPO's and secondary offerings

Week of January 22 to January 26, 2024

This Day's Priced Deals: January 25th, 2018

Symbol

Issuer

Type

Price

Managers

WMB

Williams
Williams
Block Trade
Priced: $32.75
8.6M
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
EYEN

Eyenovia
Eyenovia
IPO
Priced: $10.00
2.73M
Ladenburg & Roth MKM

Pricing after close
Deal analysis and details

Managers: Ladenburg & Roth MKM

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
GTES

Gates Industrial
Gates Industrial
IPO
Priced: $19.00
38.5M
Citi,...

Pricing after close
Deal analysis and details

Managers: Citi, Morgan Stanley & UBS, Barclays, Credit Suisse, Goldman Sachs, RBC Capital, Blackstone Capital Markets, Deutsche Bank, Wells Fargo, Current Capital, KeyBanc, Siebert, Truist, Academy, Guggenheim

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MNLO

Menlo Therapeutics
Menlo Therapeutics
IPO
Priced: $17.00
7M
Jefferies,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Jefferies, Piper Sandler & Guggenheim, JMP Securities

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ATNX

Athenex
Athenex
Secondary
Priced: $15.25
4.3M
Deutsche Bank & RBC Capital,...

Pricing after close

Managers: Deutsche Bank & RBC Capital, Needham, Ladenburg

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
BOLD

Audentes Therapeutics
Audentes Therapeutics
Secondary
Priced: $35.00
5.75M
BofA,...

Pricing after close
Deal analysis and details

Managers: BofA, TD Cowen & Leerink, Wedbush

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
EMAN

eMagin
eMagin
Secondary
Priced: $1.35
8.528M
Craig-Hallum,...

Pricing after close
Deal analysis and details

Managers: Craig-Hallum, H.C. Wainwright

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
FPRX

Five Prime
Five Prime
Secondary
Priced: $19.50
5.128M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, JPMorgan & Leerink, Wells Fargo

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ALBO

Albireo Pharma
Albireo Pharma
Spot Secondary
Priced: $33.00
1.97M
TD Cowen & William Blair,...

Pricing after close
Deal analysis and details

Managers: TD Cowen & William Blair, Needham, Wedbush, Roth MKM

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CFMS

ConforMIS
ConforMIS
Spot Secondary
Priced: $1.50
13.333M
TD Cowen & Canaccord

Pricing after close
Deal analysis and details

Managers: TD Cowen & Canaccord

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
IOVA

Iovance Biotherapeutics
Iovance Biotherapeutics
Spot Secondary
Priced: $11.50
13.044M
Jefferies

Pricing after close
Deal analysis and details

Managers: Jefferies

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
OCUL

Ocular Therapeutix
Ocular Therapeutix
Spot Secondary
Priced: $5.00
6.5M
Piper Sandler

Pricing after close
Deal analysis and details

Managers: Piper Sandler

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Deals to be Priced

01/25 - Thursday

Symbol

Issuer

Type

Price

Managers

ENTX

Entera Bio
Entera Bio
IPO
$10.00-12.00
5M
Oppenheimer,...

Pricing after close
Deal analysis and details

Managers: Oppenheimer, Ladenburg

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Priced Deals

01/22 - Monday

Symbol

Issuer

Type

Price

Managers

JMBA

Jamba
Jamba
Block Trade
Priced: $8.25
2.1M
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

01/23 - Tuesday

Symbol

Issuer

Type

Price

Managers

PAGS

PagSeguro Digital
PagSeguro Digital
IPO
Priced: $21.50
105.4M
Goldman Sachs & Morgan Stanley,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs & Morgan Stanley, BofA, BDSA, Credit Suisse, Deutsche Bank, ITAU, JPMorgan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ADMS

Adamas Pharmaceuticals
Adamas Pharmaceuticals
Secondary
Priced: $41.50
3M
BofA,...

Pricing after close
Deal analysis and details

Managers: BofA, Leerink & Evercore ISI

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
RARE

Ultragenyx
Ultragenyx
Secondary
Priced: $57.00
4.386M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, BofA, Goldman Sachs & TD Cowen

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
STML

Stemline
Stemline
Secondary
Priced: $14.00
3.7M
JPMorgan & TD Cowen

Pricing after close
Deal analysis and details

Managers: JPMorgan & TD Cowen

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
AERI

Aerie Pharmaceuticals
Aerie Pharmaceuticals
Spot Secondary
Priced: $59.20
1.3M
Cantor Fitzgerald

Pricing after close
Deal analysis and details

Managers: Cantor Fitzgerald

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
RCKT

Rocket Pharmaceuticals
Rocket Pharmaceuticals
Spot Secondary
Priced: $13.25
5.5M
TD Cowen & Evercore ISI

Pricing after close
Deal analysis and details

Managers: TD Cowen & Evercore ISI

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SYBX

Synlogic
Synlogic
Spot Secondary
Priced: $9.75
5.13M
Leerink & Piper Sandler,...

Pricing after close
Deal analysis and details

Managers: Leerink & Piper Sandler, H.C. Wainwright

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TK

Teekay Corp.
Teekay Corp.
Spot Secondary
Priced: $9.75
10M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley, BofA & UBS, BNP Paribas

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
UBSH

Union Bankshares
Union Bankshares
Spot Secondary
Priced: $38
7931926
Keefe Bruyette,...

Pricing after close

Managers: Keefe Bruyette, Sandler O'Neill, Raymond James & Barclays

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

01/24 - Wednesday

Symbol

Issuer

Type

Price

Managers

WMB

Williams
Williams
Block Trade
Priced: $32.75
8.6M
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
EYEN

Eyenovia
Eyenovia
IPO
Priced: $10.00
2.73M
Ladenburg & Roth MKM

Pricing after close
Deal analysis and details

Managers: Ladenburg & Roth MKM

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
GTES

Gates Industrial
Gates Industrial
IPO
Priced: $19.00
38.5M
Citi,...

Pricing after close
Deal analysis and details

Managers: Citi, Morgan Stanley & UBS, Barclays, Credit Suisse, Goldman Sachs, RBC Capital, Blackstone Capital Markets, Deutsche Bank, Wells Fargo, Current Capital, KeyBanc, Siebert, Truist, Academy, Guggenheim

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MNLO

Menlo Therapeutics
Menlo Therapeutics
IPO
Priced: $17.00
7M
Jefferies,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Jefferies, Piper Sandler & Guggenheim, JMP Securities

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ATNX

Athenex
Athenex
Secondary
Priced: $15.25
4.3M
Deutsche Bank & RBC Capital,...

Pricing after close

Managers: Deutsche Bank & RBC Capital, Needham, Ladenburg

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
BOLD

Audentes Therapeutics
Audentes Therapeutics
Secondary
Priced: $35.00
5.75M
BofA,...

Pricing after close
Deal analysis and details

Managers: BofA, TD Cowen & Leerink, Wedbush

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
EMAN

eMagin
eMagin
Secondary
Priced: $1.35
8.528M
Craig-Hallum,...

Pricing after close
Deal analysis and details

Managers: Craig-Hallum, H.C. Wainwright

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
FPRX

Five Prime
Five Prime
Secondary
Priced: $19.50
5.128M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, JPMorgan & Leerink, Wells Fargo

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ALBO

Albireo Pharma
Albireo Pharma
Spot Secondary
Priced: $33.00
1.97M
TD Cowen & William Blair,...

Pricing after close
Deal analysis and details

Managers: TD Cowen & William Blair, Needham, Wedbush, Roth MKM

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CFMS

ConforMIS
ConforMIS
Spot Secondary
Priced: $1.50
13.333M
TD Cowen & Canaccord

Pricing after close
Deal analysis and details

Managers: TD Cowen & Canaccord

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
IOVA

Iovance Biotherapeutics
Iovance Biotherapeutics
Spot Secondary
Priced: $11.50
13.044M
Jefferies

Pricing after close
Deal analysis and details

Managers: Jefferies

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
OCUL

Ocular Therapeutix
Ocular Therapeutix
Spot Secondary
Priced: $5.00
6.5M
Piper Sandler

Pricing after close
Deal analysis and details

Managers: Piper Sandler

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

01/25 - Thursday

Symbol

Issuer

Type

Price

Managers

AGS

PlayAGS
PlayAGS
IPO
Priced: $16.00
10.25M
Credit Suisse & Deutsche Bank,...

Pricing after close
Deal analysis and details

Managers: Credit Suisse & Deutsche Bank, Jefferies, Macquarie, BofA, Citi, Nomura, Stifel, Truist, Roth MKM, UGAM, Williams Trading, Apollo Global

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ARMO

ARMO BioSciences
ARMO BioSciences
IPO
Priced: $17.00
7.529M
Jefferies,...

Pricing after close
Deal analysis and details

Managers: Jefferies, Leerink & BMO Capital, Baird

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SLDB

Solid Biosciences
Solid Biosciences
IPO
Priced: $16.00
7.8M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, Goldman Sachs & Leerink, Nomura, Chardan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TORC

ResTORbio
ResTORbio
IPO
Priced: $15.00
5.67M
BofA,...

Pricing after close
Deal analysis and details

Managers: BofA, Leerink, Evercore ISI & Wedbush

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
GDS

GDS Holdings
GDS Holdings
Secondary
Priced: $26.00
8M
RBC Capital,...

Pricing after close
Deal analysis and details

Managers: RBC Capital, JPMorgan & Citi, TD Cowen, Guggenheim, Raymond James

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
RPD

Rapid7
Rapid7
Secondary
Priced: $22.00
5.18M
Barclays & RBC Capital,...

Pricing after close

Managers: Barclays & RBC Capital, KeyBanc, Stifel, TD Cowen, Raymond James, William Blair, BTIG

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SBBP

Strongbridge Biopharma
Strongbridge Biopharma
Secondary
Priced: $6.75
5M
Cantor Fitzgerald,...

Pricing after close

Managers: Cantor Fitzgerald, JMP Securities

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access